Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$0.5 - $0.73 $1,096 - $1,600
-2,193 Reduced 4.53%
46,240 $25,000
Q4 2023

Jan 12, 2024

BUY
$0.48 - $0.7 $2,376 - $3,465
4,951 Added 11.39%
48,433 $28,000
Q3 2023

Oct 13, 2023

BUY
$0.5 - $1.05 $6,051 - $12,707
12,102 Added 38.57%
43,482 $26,000
Q2 2023

Jul 10, 2023

SELL
$0.55 - $0.89 $118,769 - $192,191
-215,945 Reduced 87.31%
31,380 $24,000
Q1 2023

Apr 28, 2023

BUY
$0.68 - $1.25 $120,061 - $220,701
176,561 Added 249.51%
247,325 $176,000
Q4 2022

Feb 02, 2023

SELL
$0.96 - $1.34 $65,109 - $90,881
-67,822 Reduced 48.94%
70,764 $73,000
Q3 2022

Oct 31, 2022

BUY
$1.02 - $2.23 $120,585 - $263,632
118,221 Added 580.51%
138,586 $183,000
Q2 2022

Jul 29, 2022

SELL
$0.94 - $1.94 $993,788 - $2.05 Million
-1,057,222 Reduced 98.11%
20,365 $21,000
Q1 2022

Apr 29, 2022

BUY
$1.54 - $3.71 $1.56 Million - $3.76 Million
1,014,543 Added 1609.26%
1,077,587 $2.12 Million
Q4 2021

Feb 07, 2022

SELL
$2.58 - $3.91 $273,921 - $415,128
-106,171 Reduced 62.74%
63,044 $168,000
Q3 2021

Nov 01, 2021

BUY
$2.77 - $4.05 $421,062 - $615,632
152,008 Added 883.41%
169,215 $574,000
Q2 2021

Aug 12, 2021

BUY
$1.71 - $4.14 $29,423 - $71,236
17,207 New
17,207 $66,000
Q2 2020

Jul 20, 2020

SELL
$0.39 - $0.69 $18,329 - $32,429
-46,999 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$0.56 - $1.62 $17,764 - $51,389
31,722 Added 207.65%
46,999 $30,000
Q4 2019

Jan 28, 2020

BUY
$0.83 - $1.3 $12,679 - $19,860
15,277 New
15,277 $14,000
Q2 2019

Jul 29, 2019

SELL
$1.81 - $2.45 $34,138 - $46,209
-18,861 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$2.3 - $3.27 $43,380 - $61,675
18,861 New
18,861 $46,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $484M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.